| 19th Feb 2024 7:00 am |
RNS |
Tagrisso improved PFS in Stage III lung cancer |
| 8th Feb 2024 7:00 am |
RNS |
Final Results |
| 1st Feb 2024 3:00 pm |
RNS |
Total Voting Rights |
| 2nd Jan 2024 3:00 pm |
RNS |
Total Voting Rights |
| 27th Dec 2023 7:00 am |
RNS |
AstraZeneca acquires Gracell |
| 22nd Dec 2023 7:00 am |
RNS |
Wainua (eplontersen) granted first US FDA approval |
| 14th Dec 2023 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 12th Dec 2023 7:05 am |
RNS |
AstraZeneca to acquire Icosavax |
| 1st Dec 2023 3:05 pm |
RNS |
Block listing Interim Review |
| 1st Dec 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Dec 2023 7:00 am |
RNS |
Discontinuation of two CRYSTALIZE evidence trials |
| 23rd Nov 2023 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 17th Nov 2023 7:00 am |
RNS |
Truqap approved in US for HR+ breast cancer |
| 14th Nov 2023 7:05 am |
RNS |
Update on PACIFIC-2 Phase III trial for Imfinzi |
| 9th Nov 2023 3:00 pm |
RNS |
Director Declaration |
| 9th Nov 2023 7:10 am |
RNS |
Imfinzi combination improves PFS in liver cancer |
| 9th Nov 2023 7:05 am |
RNS |
Agreement with Eccogene for clinical stage GLP-1RA |
| 9th Nov 2023 7:00 am |
RNS |
9M and Q3 2023 results |
| 1st Nov 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2023 7:00 am |
RNS |
AstraZeneca cell & gene therapy deal w/ Cellectis |
| 3rd Oct 2023 7:00 am |
RNS |
AstraZeneca settles Nexium liability litigations |
| 2nd Oct 2023 3:00 pm |
RNS |
Total Voting Rights |
| 22nd Sep 2023 7:00 am |
RNS |
Dato-DXd improved PFS in breast cancer |
| 20th Sep 2023 7:00 am |
RNS |
Alexion completes Pfizer gene therapy agreement |
| 15th Sep 2023 3:00 pm |
RNS |
Enhertu recommended in EU for HER2-mutant NSCLC |
| 11th Sep 2023 4:00 pm |
RNS |
Fasenra Phase III EGPA trial met primary endpoint |
| 6th Sep 2023 7:00 am |
RNS |
Update on US review of Ultomiris for NMOSD |
| 1st Sep 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Aug 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Jul 2023 7:05 am |
RNS |
Alexion enters gene therapy agreement with Pfizer |
| 28th Jul 2023 7:00 am |
RNS |
Half-year Report |
| 17th Jul 2023 6:10 pm |
RNS |
Beyfortus approved in US for infant RSV prevention |
| 3rd Jul 2023 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Jul 2023 7:00 am |
RNS |
Dato-DXd significantly improved PFS in lung cancer |
| 9th Jun 2023 7:05 am |
RNS |
nirsevimab recommended for infant RSV protection |
| 9th Jun 2023 7:00 am |
RNS |
AstraZeneca agreement with Quell Therapeutics |
| 2nd Jun 2023 5:00 pm |
RNS |
Imfinzi improved pCR in gastric and GEJ cancers |
| 1st Jun 2023 3:05 pm |
RNS |
Block listing Interim Review |
| 1st Jun 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Jun 2023 7:00 am |
RNS |
Lynparza approved in US for BRCAm prostate cancer |
